ReiThera’s Covid-19 vaccine shows promise in Phase II trial
The vaccine was well-tolerated and its tolerability was better at the second dose with no serious adverse events reported.
Italy
Latest in
Italy
Omeros’ narsoplimab boosts survival in Covid-19 study in Italy
The Italian cohort enrolled ten subjects who received narsoplimab under compassionate use at ASST Papa Giovanni XXIII Hospital.
ReiThera’s Covid-19 vaccine shown to induce immune response in trial
Biotech firm ReiThera has reported that the preliminary results from the ongoing Phase I study showed that its Covid-19 vaccine…
Italy starts testing potential Covid-19 vaccine on healthy volunteers
Italy has started human trials of a potential Covid-19 vaccine as part of the global efforts to develop a response…
FibroGen: The company attempting to treat pneumonia in Covid-19 patients
FibroGen recently announced enrolment of patients in a clinical study of its antibody drug pamrevlumab as a potential Covid-19 treatment
By
FibroGen starts enrolment in pamrevlumab trial for Covid-19
FibroGen has started patient enrolment for a Phase II/III clinical trial of pamrevlumab for the treatment of severe Covid-19 infection…
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of countries with coronavirus, while more…
EUSA Pharma reports data of siltuximab in coronavirus trial
EUSA Pharma has reported preliminary results from the SISCO study of siltuximab for the treatment of patients with Covid-19.